Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
off-the-shelf
2:57
Adapting cell therapies to solid tumors
Nina Bauer
• 26 Jan 2022
1:47
The advantages and applications of CRISPR-Cas 9
Nina Bauer
• 27 Jan 2022
2:26
Advantages of allogeneic NK cell therapy
Kanya Rajangam
• 13 Oct 2021
2:48
Developments in NK cell therapy
Kanya Rajangam
• 13 Oct 2021
0:59
Treating hematologic malignancies with immunotherapy
Kanya Rajangam
• 13 Oct 2021
4:55
Advances in cell-based therapies for MS
Jakob Dupont
• 17 Jun 2021
5:20
ATA188: an allogeneic EBV-specific T cell therapy for progressive MS
Jakob Dupont
• 17 Jun 2021
4:08
Characterization of ATA188: an off-the-shelf therapy for MS
Jakob Dupont
• 17 Jun 2021
2:56
Allogenic NKX101 in r/r AML
James Trager
• 22 Feb 2021
4:58
Universal “off-the-shelf” CAR T-cells from iPSCs
Alexandros Nianias
• 6 Feb 2021
